Inventor
OKAWA TOMOHIRO
JP18 patents
⚠️ This page may combine multiple inventors who share the name “OKAWA TOMOHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAKEDA PHARMACEUTICALS CO
10 patentsUS10323026B2Jun 18, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO20 citations85
US10610520B2Apr 7, 2020
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO9 citations83
US11236099B2Feb 1, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations71
US11186565B2Nov 30, 2021
Aromatic compound
TAKEDA PHARMACEUTICALS CO3 citations71
US10435399B2Oct 8, 2019
HDAC6 inhibitory heterocyclic compound
TAKEDA PHARMACEUTICALS CO5 citations71
US10202376B2Feb 12, 2019
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO4 citations70
US9776962B2Oct 3, 2017
Aromatic compounds with GPR40 agonistic activity
TAKEDA PHARMACEUTICALS CO2 citations70
US11274101B2Mar 15, 2022
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations62
US12378256B2Aug 5, 2025
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations61
US12084436B2Sep 10, 2024
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations49
CARDURION PHARMACEUTICALS LLC
3 patentsUS10543212B2Jan 28, 2020
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC10 citations80
US11197858B2Dec 14, 2021
Substituted amines for treating cardiac diseases
CARDURION PHARMACEUTICALS LLC0 citations59
US11130752B2Sep 28, 2021
Aminopyrimidine compound
CARDURION PHARMACEUTICALS LLC0 citations49
TAKEDA PHARMACEUTICAL
2 patentsCARDURION PHARMACEUTICALS INC
2 patentsUS12528816B2Jan 20, 2026
Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors
CARDURION PHARMACEUTICALS INC0 citations59
US11795172B2Oct 24, 2023
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors
CARDURION PHARMACEUTICALS INC0 citations59